Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Primary idiopathic pseudopelade of Brocq causes gradual, scarring hair loss with no effective treatment.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Don't ignore acne treatment to avoid scars and emotional trauma.

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

A 35-year-old man had patchy hair loss that was actually due to syphilis, not alopecia areata.

Low SULT activity in hair follicles leads to better response to oral minoxidil for hair loss.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

EVG staining helps tell apart follicular scars from follicular streamers, aiding in diagnosing different types of hair loss.

A tick bite caused temporary hair loss in a man, which is a rare condition that usually gets better within 3 months.

The woman has a type of scarring hair loss with red bumps around hair follicles.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Platelet-rich plasma (PRP) is a simple, cost-effective treatment that promotes hair growth and reduces hair loss, with high patient satisfaction.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.